3rd Quarter - Report
ALSTON & BIRD LLP for CELGENE CORPORATION
Firm
Client
Income
$80,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues relating to prescription drugs in health care bills; orphan drug and rare disease bills; issues relating to pharmaceuticals in health reform, including pharmaceutical bills; S. 1423, Preserving Access to Orphan Drugs Act of 2011; H.R. 2672, Preserving Access to Orphan Drugs Act of 2011.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER L BUTLER | — |
| ROBERT J DOLE | — |
| JOYCE E GRESKO | — |
| ELINOR HILLER | — |
| MARK RAYDER | — |
| COLIN ROSKEY | — |
| MARC SCHEINESON | — |
| REGINA MARIA SHERICK | — |
| CAROLYN E SMITH | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.